Dr. Leonard Guarente, Professor of Biology at the Massachusetts Institute of Technology (MIT) has created an anti-aging pill that will challenge the signs of aging and will significantly slow them down.
Dr. Guarente, 61, who also heads the Glenn Laboratory for the Science and Aging, has dedicated his life’s work to finding out why living things age and how genes influence the way living creatures age.
After extensive research on aging, Dr. Leonard Guarente was able to create an anti-aging pill, which is actually a vitamin pill that not only repairs damaged DNA but it also reduces the risk of chronic diseases such as cancer and diabetes and boosts energy levels.
The anti-aging pill that the MIT professor created is called Basis and it contains elements that help regenerate Nicotinamide Adenine Dinucleotide (or NAD). NAD along with pterostilbene and resveratrol will increase the life span of animals. The scientists have already tested this on lab mice and worms and they not only lived longer, but their bodies were much younger than their actual age.
The anti-aging pills is going to hit the shelves sooner than you would think. Basis is going to be available as early as next week and it will be sold for $60 for a 30 day supply $50 a month for a regular subscription.
Basis bottles will contain 60 capsules and the anti-aging pill is going to be only be sold in the store that Guarente founded and did research for, a startup company called Elysium Health.
What is truly encouraging is the fact that Basis, the anti-aging pill, has support from 5 Nobel laureates, including Jack Szostak. He received the coveted award in 2009 after he discovered that telomeres protect the DNA.
Nir Barzilai, who is the director of the Insitute of Aging Research with the Albert Einstein College of Medicine in New York, has coauthored several research papers with Guarente, but is not involved in Elysium.
If you’re wondering why the anti-aging pill is released so quickly, it is because it is registered as a vitamin pill, which means that it does not have to go through Food and Drug Administration approval. According to Dr. Guarente, the process is unnecessary and it would cost money and time.
Image Source: MIT